AstraZeneca and Geisinger join forces to create new asthma app

| By | AstraZeneca, R&D
0
168

AstraZeneca and Geisinger have partnered to improve asthma care by creating a suite of products that integrate into the electronic health record (EHR).

The goal is to engage patients and providers in co-managing the disease, especially during intervals between office visits.

Geisinger (Danville, Pennsylvania, USA) is an integrated health services organization widely recognized for its innovative use of the electronic health record and the development of innovative care delivery models

The mobile app data is connected to a real-time, web-based application called Provider Asthma Management Assistant. The assistant combines EHR and patient-reported data feeds to enable asthma educators and respiratory therapists to triage patients on the fly and bring in specialists as needed.

Asthma is a chronic respiratory disease where the airways in the lungs become swollen or inflamed making it difficult to breath. Asthma symptoms can vary over time and worsening of asthma (an asthma attack) can be triggered by environmental exposure or allergies. There is no cure for asthma, but it can be managed.

The new asthma app suite includes a mobile app that allows patients to view asthma-related weather forecasts, log symptoms and asthma triggers, establish medication reminders, track health status over time, and, crucially, communicate with their healthcare team. Some asthma patients can have multiple attacks per week, and it isn’t feasible or necessary to see a doctor every time. With the new app products, attacks and symptoms can be tracked and easily monitored in real-time by the full spectrum of the health care team.

Geisinger and AstraZeneca’s partnership in developing the asthma app suite uses scientific expertise from both companies in disease management, patient engagement, adherence, healthcare innovation, research, and technology to fundamentally redesign how asthma patients are diagnosed and treated.

SOURCE: geisinger
SHARE
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.